Kevin C. Zorn

Nov 13, 2024 | urologytimes.com | Kevin C. Zorn

In this video, Kevin C. Zorn, MD, FRCSC, FACS, discusses the implications of findings from the study, “An analysis of benign prostatic hyperplasia surgical treatment reimbursement trends across Canada: Examining provincial changes over the recent decade with comparison to cost of living changes,” for which he served as the senior author. Overall, the study showed variations in the reimbursement for BPH treatments across Canada, as well as rates that failed to keep up with inflation.

Nov 7, 2024 | urologytimes.com | Kevin C. Zorn

In this video, Kevin C. Zorn, MD, FRCSC, FACS, describes the background and notable findings from the study, “An analysis of benign prostatic hyperplasia surgical treatment reimbursement trends across Canada: Examining provincial changes over the recent decade with comparison to cost of living changes,” for which he served as the senior author. Zorn is the founder and director of BPH Canada in Montreal, Canada. Video Transcript:Could you describe the background/rationale for this study?

Nov 7, 2024 | theritchiegazette.com | Kevin C. Zorn

Of the locations Virginia’s 1858 government had reviewed for a third hospital, Weston in Lewis County might not have seemed best. Wheeling certainly had a larger population and was quickly becoming a center of industry; Vandalia, now Fayetteville, offered a great location with nearby access to the New River, and Sutton in Braxton County had long been established as a transportation hub via its connection of the Weston and Gauley Bridge Turnpike to the Staunton and Parkersburg Turnpike.

Apr 25, 2024 | nature.com | Naeem Bhojani |Larry Miller |Kevin C. Zorn |Dean Elterman

AbstractShared decision-making (SDM) is recommended for prostate-specific antigen (PSA) testing but appears underutilized. This population-based study assessed the prevalence and determinants of SDM for PSA testing among US men. We assessed PSA testing rates and SDM engagement in men aged 40 and older without prostate cancer history using the 2019 National Health Interview Survey. SDM was defined as discussing the advantages and disadvantages of PSA testing with a physician.

Sep 11, 2023 | einpresswire.com | Kevin C. Zorn

Dr. Kevin C. Zorn, MD, FRCSC, FACSBPH Canada offers a dedicated and proactive approach to prostate health care during the month of September and beyond. BPH isn’t prostate cancer and doesn’t make you more likely to get it. The incidence of BPH is far higher than prostate cancer.”— Dr. Kevin C. Zorn, MD, FRCSC, FACSMONTREAL, QC, CANADA, September 11, 2023/ EINPresswire.com/ -- To help men make informed decisions about their health, September is recognized as Prostate Health Month.